Evidence map›Paper›PMID 30238630›Full record

ArticleJournal of clinical hypertension (Greenwich, Conn.)2018

Sex differences in adherence to antihypertensive treatment in patients aged above 55: The French League Against Hypertension Survey (FLAHS).

Mathilde Lefort, Lola Neufcourt, Bruno Pannier, Bernard Vaïsse, Sahar Bayat, Olivier Grimaud, Xavier Girerd

Abstract readComparative Study
In one paragraph

Article in Journal of clinical hypertension (Greenwich, Conn.), 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Trial
  3. Observational
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. The impact of sex on blood pressure.Current opinion in nephrology and hypertension · 2025
    Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Drugs don't work in patients who don't take them.Journal of clinical hypertension (Greenwich, Conn.) · 2018
    Article
  16. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

7 authors.

Mathilde LefortUniv Rennes, EHESP, REPERES (Recherche en Pharmaco-épidémiologie et Recours aux Soins) - EA 7449, Rennes, France.
Lola NeufcourtUniv Rennes, EHESP, REPERES (Recherche en Pharmaco-épidémiologie et Recours aux Soins) - EA 7449, Rennes, France.ORCID 0000-0001-6429-0551
Bruno PannierComité Français de Lutte Contre l'Hypertension Artérielle (CFLHTA), Paris, France.
Bernard VaïsseComité Français de Lutte Contre l'Hypertension Artérielle (CFLHTA), Paris, France.
Sahar BayatUniv Rennes, EHESP, REPERES (Recherche en Pharmaco-épidémiologie et Recours aux Soins) - EA 7449, Rennes, France.
Olivier GrimaudUniv Rennes, EHESP, REPERES (Recherche en Pharmaco-épidémiologie et Recours aux Soins) - EA 7449, Rennes, France.
Xavier GirerdComité Français de Lutte Contre l'Hypertension Artérielle (CFLHTA), Paris, France.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Despite the availability of efficient therapies to reduce the risk of cardiovascular complications, poor adherence to antihypertensive (anti-HTN) drugs is frequent, especially during the first year of treatment and among uncontrolled/resistant hypertensive patients. The aim of the study was to identify factors associated with adherence to anti-HTN treatment and to examine whether they differ across sex. A total of 2743 treated hypertensive participants to the cross-sectional Metascope survey (France, 2015) aged 55 years or more were included. The authors measured adherence to anti-HTN treatment using the 6-item Girerd compliance test. Variations in adherence were examined using the Rao-Scott statistics and Poisson regression. Overall, 63.6% of participants were adherent to anti-HTN treatment. Adherence was more frequent among women than men (69% vs 58%, P < 10

Indexed as

Drug MonitoringSex CharacteristicsAgedAged, 80 and overAntihypertensive AgentsCardiovascular DiseasesComorbidityCross-Sectional StudiesFemaleFranceHumansHypertensionMaleMiddle AgedSurveys and QuestionnairesTabletsAntihypertensive AgentsTabletsantihypertensive drugsdeterminants of adherencehypertensionmedication adherencesex differences

Identifiers

PMID30238630
PMCPMC8030937

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.